ジンバブエ - 英語 - Medicines Control Authority

getrude murodzi - blackseed oil - capsule - 100mg

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

csl limited - black snake antivenom; phenol - parenteral liquid/solution/suspension - black snake antivenom antivenom-snake active 18000.0 units; phenol phenol other 0.25 %w/v - immunotherapy - animal - vaccines and antisera | brown snake bite | cheesy gland | enterotoxaemia | tetanus

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

hevert pharmaceuticals llc - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), anamirta cocculus seed (unii: 810258w28u) (anamirta cocculus seed - unii:810258w28u), cypripedium parviflorum var. pubescens root (unii: 21y9gz1lza) (cypripedium parviflorum var. pubescens root - unii:21y9gz1lza), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), passiflora incarnata flowering top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), platinum (unii: 49dfr088my) (p - black cohosh 4 [hp_x] in 2 ml - 1.1 hevert® calmvalera™ comp. is a homeopathic drug indicated for the treatment of nervous disorders, such as restlessness and sleep disorders, mild depressive states, and mental exhaustion. hevert® calmvalera™ comp. is contraindicated in patients with known hypersensitivity to lady's slipper or orchids, or to any of its ingredients. animal reproduction studies have not been performed with hevert® calmvalera™ comp. or any of its ingredients. there are not adequate and well-controlled studies in pregnant women. hevert® calmvalera™ comp. should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. no non-teratogenic effects are known. no recognized use in labor or delivery. it is not known whether hevert® calmvalera™ comp. is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when hevert® calmvalera™ comp. is administered to a nursing woman. safety and effectiveness in pediatric patients have not been established.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

merck sharp & dohme llc - black widow spider (latrodectus mactans) immune globulin antivenin (equine) (unii: 5vja14972g) (black widow spider (latrodectus mactans) immune globulin antivenin (equine) - unii:5vja14972g) - black widow spider (latrodectus mactans) immune globulin antivenin (equine) 6000 [iu] in 2.5 ml - antivenin (latrodectus mactans ) is used to treat patients with symptoms due to bites by the black widow spider (latrodectus mactans ). early use of the antivenin is emphasized for prompt relief. local muscular cramps begin from 15 minutes to several hours after the bite which usually produces a sharp pain similar to that caused by puncture with a needle. the exact sequence of symptoms depends somewhat on the location of the bite. the venom acts on the myoneural junctions or on the nerve endings, causing an ascending motor paralysis or destruction of the peripheral nerve endings. the groups of muscles most frequently affected at first are those of the thigh, shoulder, and back. after a varying length of time, the pain becomes more severe, spreading to the abdomen, and weakness and tremor usually develop. the abdominal muscles assume a boardlike rigidity, but tenderness is slight. respiration is thoracic. the patient is restless and anxious. feeble pulse, cold, clammy skin, labored breathing and speech, light

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

hevert arzneimittel gmbh & co. kg - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), anamirta cocculus seed (unii: 810258w28u) (anamirta cocculus seed - unii:810258w28u), cypripedium parviflorum var. pubescens root (unii: 21y9gz1lza) (cypripedium parviflorum var. pubescens root - unii:21y9gz1lza), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), lilium lancifolium flowering top (unii: 6268mfa917) (lilium lancifolium flowering top - unii:6268mfa917), passiflora incarnata flowering top - black cohosh 4 [hp_x] - for temporary relief of minor symptoms of tension and stress, such as: - restlessness - mild mood changes - temporary anxiety - occasional sleeplessness these statements have not been evaluated by the food and drug administration. they are supported by traditional homeopathic principles.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

laboratoires boiron - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), citrullus colocynthis fruit pulp (unii: 23h32aoh17) (citrullus colocynthis fruit pulp - unii:23h32aoh17), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838) - black cohosh 6 [hp_c] - temporarily relieves symptoms associated with menstrual cramps such as: discomfort, minor aches and pain do not use if glued carton en flaps are open or if the blister seal is broken cimicifuga racemosa 6c ...relieves menstrual cramps with aches and pains radiating to the thighs colcynthis 6c...relieves menstrual cramps magnesia phosphorica 6c... relieves menstrual cramps improved by warmth stop use and ask a doctor if symptoms persist for more than 7 days or worsen.

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - black pepper allergen extract - solution for skin-prick test

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

lasius niger) 1mg/ml solution for skin prick test (inmunotek - black ant (lasius niger) allergen extract - solution for skin-prick test

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

blackmores ltd - riboflavine, quantity: 8.5 mg; nicotinamide, quantity: 60 mg; calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); ascorbic acid, quantity: 300 mg; pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.23 mg); cyanocobalamin, quantity: 10 microgram; folic acid, quantity: 200 microgram; thiamine nitrate, quantity: 7.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; sodium starch glycollate; purified talc; lecithin; calcium hydrogen phosphate dihydrate; curcumin; microcrystalline cellulose; glycerol; carnauba wax; hypromellose

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

blackmores ltd - calcium pantothenate, quantity: 21.8 mg (equivalent: pantothenic acid, qty 20 mg); pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.23 mg); ascorbic acid, quantity: 180 mg; manganese sulfate monohydrate, quantity: 6.16 mg (equivalent: manganese, qty 2 mg); biotin, quantity: 25 microgram; inositol, quantity: 25 mg; heavy magnesium oxide, quantity: 30.63 mg (equivalent: magnesium, qty 17.5 mg); zinc oxide, quantity: 6.2 mg (equivalent: zinc, qty 5 mg); folic acid, quantity: 200 microgram; calcium carbonate, quantity: 100 mg (equivalent: calcium, qty 40 mg); ferrous sulfate, quantity: 16 mg (equivalent: iron, qty 5 mg); choline bitartrate, quantity: 25 mg; d-alpha-tocopheryl acid succinate, quantity: 16.53 mg; potassium sulfate, quantity: 55.75 mg (equivalent: potassium, qty 25 mg); riboflavine, quantity: 8.5 mg; cyanocobalamin, quantity: 10 microgram; nicotinamide, quantity: 60 mg; thiamine nitrate, quantity: 7.5 mg; colecalciferol, quantity: 0.01 mg; retinol palmitate, quantity: 2.75 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; titanium dioxide; hypromellose; magnesium stearate; calcium hydrogen phosphate dihydrate; glycerol; iron oxide yellow; carnauba wax; hydrogenated vegetable oil; chlorophyllin-copper complex; sodium starch glycollate; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; potable water; gelatin; butylated hydroxytoluene; aluminium starch octenylsuccinate; aluminium sodium silicate